These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36845750)

  • 1. The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer.
    Zhao R; Wang W; Pan L; Lv X; He Y; Lian W; Ma Y; Zhang X; Yu R; Zhao S; Guo X; Huang T; Peng M
    Front Oncol; 2023; 13():1047973. PubMed ID: 36845750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer.
    Gu L; Hu G; Hu J; Wen F
    Heliyon; 2023 Aug; 9(8):e18848. PubMed ID: 37593621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
    Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
    Front Genet; 2021; 12():790888. PubMed ID: 34976022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.
    Li Q; Tang Y; Wang T; Zhu J; Zhou Y; Shi J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):307-323. PubMed ID: 36575346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy.
    Liao X; Liu H; Zhang Z; Zhang J; Zhang C; Zhao W
    Front Genet; 2022; 13():1010787. PubMed ID: 36338964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma.
    Peng L; Xu S; Xu JL
    J Hepatocell Carcinoma; 2024; 11():879-900. PubMed ID: 38770169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer.
    Cao X; Zhou X; Chen C; Wang Z; Sun Q
    Front Cell Dev Biol; 2022; 10():962389. PubMed ID: 36393842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer.
    Cheng XY; Liang Y; Zhang HF; Qian FZ; Sun XH; Liu XA
    Am J Transl Res; 2023; 15(4):2598-2609. PubMed ID: 37193173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
    Li W; Zhang X; Chen Y; Pang D
    Front Oncol; 2022; 12():966511. PubMed ID: 36212436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer.
    Kang Z; Sun JB; Lin F; Huang XY; Huang Q; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y
    Front Oncol; 2023; 13():1160972. PubMed ID: 37346077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an Immunogenic Cell Death-Related Gene Signature and Genetic Subtypes for Predicting Prognosis, Immune Microenvironments, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li S; Zhang T; Sun X; Li X
    J Inflamm Res; 2024; 17():2427-2444. PubMed ID: 38681068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer.
    Wang Y; Yue T; He Q
    Aging (Albany NY); 2023 Sep; 15(17):8833-8850. PubMed ID: 37695742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer.
    Zhu L; Wu Y; Zhao H; Guo Z; Bo B; Zheng L
    Sci Rep; 2024 Jan; 14(1):2025. PubMed ID: 38263419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.